We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial

News   May 09, 2013

 
Aileron Therapeutics Successfully Completes First-Ever Stapled Peptide Clinical Trial
 
 
 

RELATED ARTICLES

Common Disease Mechanism for ALS and Frontotemporal Dementia

News

Findings suggest mutations leading to accumulation of RNA-binding proteins to blame for disease, and could offer route for early diagnosis

READ MORE

Scientists Discover Intricacies of Serotonin Receptor Crucial for Better Drugs

News

Researchers have figured out precisely why one drug binds to the serotonin receptor 5-HT2BR and activates it to cause heart problems while very similar drugs do not. They've also discovered why a third drug acts like a 5-HT2BR antagonist - it blocks the receptor's activity - while the very well-known similar hallucinogenic drug LSD does not.

READ MORE

Novel Histone-Tracking Tool Unlocks New Insights into Epigenetic Cellular Memory

News

The way daughter cells inherit histones is a highly controlled process, and may be highly influential on development.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE